FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older
29 juil. 2022 16h05 HE
|
Arcutis Biotherapeutics, Inc.
First and only topical PDE4 inhibitor approved for the treatment of plaque psoriasis, including intertriginous psoriasis Approved for once-daily treatment in mild, moderate, and severe plaque...
Evelo Biosciences Announces Appointment of Marella Thorell as Chief Financial Officer
18 juil. 2022 06h00 HE
|
Evelo Biosciences, Inc.
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on...
Insights on the Dermatology Diagnostic Devices Global Market to 2027 - by Product Type, End-use and Region
27 mai 2022 08h13 HE
|
Research and Markets
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Dermatology Diagnostic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights
12 mai 2022 10h47 HE
|
Evelo Biosciences, Inc.
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, May 12 by Evelo Biosciences, Inc. (Nasdaq: EVLO), please note that in the first sentence...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of PH-10 Immuno-Dermatology Agent for Treatment of Inflammatory Dermatoses and Epithelial Diseases
03 mai 2022 06h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, May 03, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent (USP) application 16/204,832,...
Mindera Health™ Launches Pilot with National Health Insurance Company to Improve Management of Moderate-To-Severe Psoriasis Patients Through Precision Medicine
28 avr. 2022 08h00 HE
|
Mindera Health
San Diego, CA, April 28, 2022 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of the groundbreaking Dermal Intelligence™ platform - the first realization of precision medicine in psoriasis, has...
The Worldwide Skin Boosters Industry is Expected to Reach $1.5 Billion by 2027
26 avr. 2022 07h43 HE
|
Research and Markets
Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Global Skin Boosters Market Size, Share & Industry Trends Analysis Report By Type (Mesotherapy and Micro-needle), By Gender (Female and Male), By...
Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors
21 avr. 2022 06h00 HE
|
Evelo Biosciences, Inc.
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today...
Evelo Biosciences Provides Updated Guidance on Advancing Clinical Inflammation Programs
14 avr. 2022 06h00 HE
|
Evelo Biosciences, Inc.
–Guidance on registration trials for EDP1815 in psoriasis expected in 3Q 2022––Data from initial cohort of patients in Phase 2 trial of EDP1815 in atopic dermatitis expected 1Q 2023––Faster release...
European Dermatology Excimer Laser Industry to 2027 - Key Drivers and Challenges
14 avr. 2022 05h43 HE
|
Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Europe Dermatology Excimer Laser Market By Product, By Application, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027" report has...